The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
In the face of senators' criticism, Moderna CEO Stéphane Bancel did not agree to lower the commercial cost of the company's COVID-19 vaccine in a hearing Wednesday on the vaccine's price.
An appeals court has ruled resoundingly in favor of an Ojai pharmacy and 21 other independent drugstores that claim massive PBM Optum Rx underpays medication reimbursements in an effort to push them out of existence.
Sanofi agreed to buy Provention Bio Inc. in a $2.9 billion deal intended to bolster the French drugmaker's portfolio of diabetes medicines with a new therapy recently approved in the U.S.
Novo Nordisk said this week it will slash the list prices of several of its popular pre-filled insulin pens and vials by up to 75%, becoming the latest drugmaker to reduce the cost of the critical medicine for diabetes patients.